Financials
- Market Capitalization 3.84 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.56
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1518 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 35.58 USD | -4.30% | -10.58% | +82.46% | +276.51% | 3.96 B USD | ||
| 1521 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 40.61 USD | -2.78% | +0.84% | +12.46% | +24.65% | 3.92 B USD | ||
| 1537 | VKTX Viking Therapeutics, Inc. - Common Stock | 32.57 USD | -3.81% | -5.26% | -3.78% | +17.75% | 3.80 B USD | ||
| 1551 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.28 USD | -0.88% | -0.70% | +9.73% | +78.76% | 3.82 B USD |